N (%)
|
41 (26.8)
|
112 (73.2)
| |
Gender, female n (%)
|
25 (61.0)
|
52 (46.4)
|
0.3
|
Duration of diabetes (year), median [IQR]
|
8.0 [17.0]
|
10.0 [13.0]
|
0.4
|
Age (year), mean ± SD
|
27.7 ± 15.2
|
26.3 ± 15.7
|
0.6
|
Mean age at diagnosis (year), mean ± SD
|
15.1 ± 10.6
|
15.2 ± 9.9
|
0.9
|
Age range, n (%)
|
1–13 year
|
9 (22.0)
|
9 (8.0)
| |
14–19 year
|
8 (19.6)
|
30 (26.8)
|
0.055
|
> 19 year
|
24 (58.6)
|
73 (65.2)
| |
Years of study (year), mean ± SDa
|
9.6 ± 4.8
|
10.3 ± 3.6
|
0.3
|
Time of follow-up (year), median [IQR]
|
8 [17.0]
|
9 [13.7]
|
0.3
|
Ethnicity, n (%)
|
Caucasian
|
24 (58.5)
|
57 (50.9)
|
0.2
|
Economic status, n (%)
| | |
0.6
|
High
|
0
|
0
| |
Medium
|
10 (24.4)
|
20 (17.9)
| |
Low
|
27 (65.9)
|
83 (74.1)
| |
Very low
|
4 (9.8)
|
9 (8.0)
| |
Living in Rio de Janeiro City, yes n (%)
|
31 (75.6)
|
90 (80.4)
|
0.5
|
Insulin U/kg
|
0.8 ± 0.4
|
0.8 ± 0.2
|
0.8
|
Glycemic control
|
HbA1c (%), baseline
|
8.9 ± 1.8
|
9.6 ± 2.3
|
0.08
|
HbA1c (mmol/mol), baseline
|
82.1 ± 25.9
|
74.6 ± 20.8
| |
HbA1c (%), final
|
8.6 ± 1.6
|
9.1 ± 1.9
|
0.1
|
HbA1c (mmol/mol), final
|
76.9 ± 21.3
|
70.9 ± 17.6
| |
HbA1c (%), mean in 1 year
|
8.7 ± 1.3
|
9.4 ± 1.8
|
0.01
|
HbA1c (mmol/mol), mean in 1 year
|
79.8 ± 19.5
|
71.7 ± 14.2
| |
HbA1c (good), baseline; n (%)b
|
7 (17.0)
|
18 (16.0)
|
0.5
|
HbA1c baseline ≥ 9.0%; n (%)c
|
18 (43.9)
|
62 (55.5)
|
0.4
|
Hb1Ac (good), final; (%)b
|
3 (7.3)
|
10 (8.9)
|
0.2
|
HbA1c final ≥ 9.0%; n (%)c
|
12 (29.2)
|
52 (46.4)
|
0.09
|
HbA1c (good) (mean), (%)b
|
3 (7.3)
|
6 (5.4)
|
0.3
|
HbA1c mean, ≥ 9.0%; n (%)c
|
15 (36.5)
|
54 (48.2)
|
0.2
|
Diabetes management
|
SMBG, n
|
3.4 ± 1.1
|
3.2 ± 1.2
|
0.3
|
Supply of glucose strips from SUS, n (%)
|
33 (80.5)
|
70 (62.5)
|
0.04
|
Adherence to diet, yes n (%)
|
15 (36.6)
|
19 (17.0)
|
0.01
|
BMI (kg/m2)
|
22.5 ± 4.5
|
23.7 ± 4.8
|
0.2
|